Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
udonitrectag
- Development stage
- Phase 2
- Lead developer
- Recordati
- Modality
- Modified Peptides → Peptides, Small Molecules
- Administration
- Ophthalmic, Topical
01
Overview
Udonitrectag is a low molecular weight, synthetic peptido-mimetic of human nerve growth factor (NGF), designed to mimic the activity of NGF by binding to and activating neurotrophin receptors. It acts as an agonist at the p75 neurotrophin receptor (p75NTR) and tropomyosin receptor kinase A (TrkA) receptor, promoting cell survival, differentiation, and trophic support. Udonitrectag is being developed primarily for ophthalmic indications such as keratitis and neurotrophic keratitis but has also been investigated for diabetic foot ulcer, choroideraemia, reperfusion injury, skin disorders, varicose ulcer, pressure ulcer, retinitis pigmentosa, among others. The drug has orphan designation for transplant rejection and keratitis. Its mechanism involves inhibition of apoptosis and autophagy in addition to its neuroprotective effects[3][5][6].
- Other names
- udonitrectag lysine salt
02
Targets
NTRK1 (Tropomyosin-related receptor kinase A)NGFR (p75NTR)
Beyond the preview
Go deeper on udonitrectag.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on udonitrectag.